American Journal of Neuroradiology 22:1901-1914 (November 2001)
© 2001 American Society of Neuroradiology
BRAIN
Etiology of Cortical and White Matter Lesions in Cyclosporin-A and FK-506 Neurotoxicity
a From the Departments of Radiology (W.S.B., M.P.S., L.L.) and Medicine (Z.Z., R.K.S., J.L.), The Western Pennsylvania Hospital, Pittsburgh.
BACKGROUND AND PURPOSE: The etiology of the neurotoxicity associated with cyclosporin-A (CsA) and FK-506 treatment is not fully understood. At our institution, we noticed a distinct, abrupt change in the imaging characteristics of CsA and FK-506 neurotoxicity, which consisted of a shift in lesion morphology from a white matter abnormality to a mixed cortical and white matter pattern. The purpose of this study was to assess clinical parameters that might explain this change.
METHODS: Twenty-two patients had a neurotoxic reaction and brain imaging changes while receiving CsA or FK-506. Nineteen patients received allogeneic bone marrow transplants, and three had aplastic marrow disorders. Fifty-one imaging studies (CT or MR imaging) were obtained, and lesion characteristics, locations, and time courses were evaluated along with relevant clinical data.
RESULTS: Nine patients who had been conditioned for transplantation with cyclophosphamide and chemotherapy (busulfan or thiotepa) had a mixed pattern of cortical and white matter involvement (57 lesions). Isolated white matter involvement (62 lesions) developed in three nontransplant patients and 10 transplant patients conditioned with cyclophosphamide and total-body irradiation. All lesions occurred at typical brain watershed zones. Lesion enhancement was noted in two patients conditioned with chemotherapy. Initial images demonstrated characteristic lesions in 15 patients (68%). Initial images were normal in four patients (18%) and nonspecific in three patients (14%).
CONCLUSION: Lesion location in CsA and FK-506 neurotoxicity may depend on the presence or type of conditioning used before bone marrow transplantation. Nontransplant patients or those conditioned with total-body irradiation develop white matter lesions, whereas those conditioned with chemotherapy develop mixed cortical and white matter lesions.
This article has been cited by other articles:
 |
|
 |
|
  A. M. McKinney, S. A. Kieffer, R. T. Paylor, K. S. SantaCruz, A. Kendi, and L. Lucato Acute Toxic Leukoencephalopathy: Potential for Reversibility Clinically and on MRI With Diffusion-Weighted and FLAIR Imaging Am. J. Roentgenol., July 1, 2009; 193(1): 192 - 206. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Horbinski, W.S. Bartynski, E. Carson-Walter, R.L. Hamilton, H.P. Tan, and S. Cheng Reversible Encephalopathy after Cardiac Transplantation: Histologic Evidence of Endothelial Activation, T-Cell Specific Trafficking, and Vascular Endothelial Growth Factor Expression AJNR Am. J. Neuroradiol., March 1, 2009; 30(3): 588 - 590. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.S. Bartynski Posterior Reversible Encephalopathy Syndrome, Part 1: Fundamental Imaging and Clinical Features AJNR Am. J. Neuroradiol., June 1, 2008; 29(6): 1036 - 1042. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.S. Bartynski Posterior Reversible Encephalopathy Syndrome, Part 2: Controversies Surrounding Pathophysiology of Vasogenic Edema AJNR Am. J. Neuroradiol., June 1, 2008; 29(6): 1043 - 1049. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.S. Bartynski, H.P. Tan, J.F. Boardman, R. Shapiro, and J.W. Marsh Posterior Reversible Encephalopathy Syndrome after Solid Organ Transplantation AJNR Am. J. Neuroradiol., May 1, 2008; 29(5): 924 - 930. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.S. Bartynski and J.F. Boardman Catheter Angiography, MR Angiography, and MR Perfusion in Posterior Reversible Encephalopathy Syndrome AJNR Am. J. Neuroradiol., March 1, 2008; 29(3): 447 - 455. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. H. Lee, E. F. M. Wijdicks, E. M. Manno, and A. A. Rabinstein Clinical Spectrum of Reversible Posterior Leukoencephalopathy Syndrome Arch Neurol, February 1, 2008; 65(2): 205 - 210. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. McKinney, J. Short, C. L. Truwit, Z. J. McKinney, O. S. Kozak, K. S. SantaCruz, and M. Teksam Posterior Reversible Encephalopathy Syndrome: Incidence of Atypical Regions of Involvement and Imaging Findings Am. J. Roentgenol., October 1, 2007; 189(4): 904 - 912. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.S. Bartynski and J.F. Boardman Distinct Imaging Patterns and Lesion Distribution in Posterior Reversible Encephalopathy Syndrome AJNR Am. J. Neuroradiol., August 1, 2007; 28(7): 1320 - 1327. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.S. Bartynski, J.F. Boardman, Z.R. Zeigler, R.K. Shadduck, and J. Lister Posterior Reversible Encephalopathy Syndrome in Infection, Sepsis, and Shock AJNR Am. J. Neuroradiol., November 1, 2006; 27(10): 2179 - 2190. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Mehall, J. L. Leach, and W. H. Merrill Posterior reversible encephalopathy syndrome after nontransplant cardiac surgery J. Thorac. Cardiovasc. Surg., November 1, 2005; 130(5): 1473 - 1474. [Full Text] [PDF]
|
|
|
|
|
|
N. Besenski, Z. Rumboldt, O. Emovon, J. Nicholas, S. Kini, J. Milutinovic, and M. N. Budisavljevic Brain MR Imaging Abnormalities in Kidney Transplant Recipients AJNR Am. J. Neuroradiol., October 1, 2005; 26(9): 2282 - 2289. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D Beckett and J Olliff Non-infectious manifestations of stem cell transplantation Br. J. Radiol., March 1, 2005; 78(927): 272 - 281. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Jaster and J. Dalmau Antibodies to Zic4 in paraneoplastic neurologic disorders and small-cell lung cancer Neurology, October 12, 2004; 63(7): 1339 - 1339. [Full Text] [PDF]
|
|
|
|
 |
|
 K. Griva, S. Hansraj, D. Thompson, D. Jayasena, A. Davenport, M. Harrison, and S. P. Newman Neuropsychological performance after kidney transplantation: a comparison between transplant types and in relation to dialysis and normative data Nephrol. Dial. Transplant., July 1, 2004; 19(7): 1866 - 1874. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Bianco, F. Fattapposta, N. Locuratolo, A. Pierallini, M. Rossi, F. Ruberto, and L. Bozzao Reversible diffusion MRI abnormalities and transient mutism after liver transplantation Neurology, March 23, 2004; 62(6): 981 - 983. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. S. Bartynski, Z. R. Zeigler, R. K. Shadduck, and J. Lister Pretransplantation Conditioning Influence on the Occurrence of Cyclosporine or FK-506 Neurotoxicity in Allogeneic Bone Marrow Transplantation AJNR Am. J. Neuroradiol., February 1, 2004; 25(2): 261 - 269. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-T. Lin, S.-J. Wang, J.-L. Fuh, L.-T. Hsiao, J.-F. Lirng, and P.-M. Chen Prolonged Reversible Vasospasm in Cyclosporin A-Induced Encephalopathy AJNR Am. J. Neuroradiol., January 1, 2003; 24(1): 102 - 104. [Abstract] [Full Text] [PDF]
|
|